This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignees: Nima Acquisition, LLC, Sapphire Biotech, Inc.. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: Innovations by Alim Seit-Nebi: Advancements in Antibody Technologies
Introduction
Alim Seit-Nebi, an accomplished inventor based in San Diego, California, has made significant contributions to the field of biotechnology with a focus on antibody technologies. With three patents to his name, his work has also involved collaborations with reputable companies in the industry.
Latest Patents
Among his latest innovations is a patent for "Nucleic acids encoding anti-gliadin antibodies." This invention outlines anti-gliadin antibodies and antibody fragments, as well as polypeptides encoding these antibodies or fragments. The patent further details methods and kits for utilizing such antibodies, fragments, or polypeptides in the detection of gliadin. Another notable patent focuses on "Neutralizing antibody testing and treatment," which presents methods, devices, and kits designed for detecting neutralizing antibodies to SARS-CoV-2, reflecting the current demand for rapid and reliable diagnostic tools.
Career Highlights
Alim Seit-Nebi has accumulated valuable experience working with various organizations. He has been associated with Nima Acquisition, LLC and Sapphire Biotech, Inc., both of which have provided a platform for him to advance his research and innovations in the biotech sector.
Collaborations
Throughout his career, Alim has collaborated with other professionals in his field, including Jingqing Zhang and Shireen Taleghani Yates. These partnerships have contributed to the success of his research projects and the development of his patented technologies.
Conclusion
Alim Seit-Nebi's work exemplifies the impact of innovative thinking in biotechnology. His patents not only address critical health concerns, such as gliadin detection and neutralizing antibody testing for viruses like SARS-CoV-2, but also highlight the importance of teamwork and collaboration in advancing scientific knowledge and technology. As he continues to innovate, Alim remains a significant figure in the field of antibody research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile